PTC Therapeutics to Participate at Upcoming Investor Conferences Oct 31, 2025 08:00AM
Citi Opens Upside 30d Catalyst Watch on PTC Therapeutics (PTCT) Jul 25, 2025 08:35AM
Citi Reiterates Neutral Rating on PTC Therapeutics (PTCT) Jun 2, 2025 10:33AM
Citi Upgrades PTC Therapeutics (PTCT) to Neutral May 7, 2025 03:35AM
PTC Therapeutics (PTCT) PT Raised to $32 at Citi Dec 4, 2024 05:50AM


Nov 4, 2024 04:30PM PTC Therapeutics to Participate at Upcoming Investor Conferences
Oct 15, 2024 05:42AM Citi Reiterates Sell Rating on PTC Therapeutics (PTCT)
Jun 20, 2024 01:03PM Citi Reiterates Sell Rating on PTC Therapeutics (PTCT), 'PIVOT-HD Data Update Supportive, But Expectations Measured to this Point'
Oct 27, 2023 06:01AM Citi Downgrades PTC Therapeutics (PTCT) to Sell, 'Regulatory Headwinds Compound'
Aug 30, 2023 08:00AM PTC Therapeutics to Participate at Upcoming Investor Conferences
May 17, 2023 02:43PM PTC Therapeutics (PTCT) PT Raised to $70 at Citi, 'Post-data, we increased our sepiapterin POS to 90%'
Jan 5, 2021 05:21AM UPDATE: Citi Upgrades PTC Therapeutics (PTCT) to Buy
Oct 30, 2020 10:15AM Citi Downgrades PTC Therapeutics (PTCT) to Neutral
Feb 20, 2020 04:55AM UPDATE: Citi Downgrades PTC Therapeutics (PTCT) to Neutral
Sep 26, 2019 06:57AM PTC Therapeutics (PTCT) Reiterated Buy at Citi Ahead of Risdiplam Data
Sep 3, 2019 03:29AM PTC Therapeutics (PTCT) PT Raised to $62 at Citi
Jun 28, 2019 08:53AM Pre-Open Movers 06/28: (CDMO) (CAMP) (PRGS) (LJPC) (STZ) (BAC) (SRNE) (more...)
May 3, 2019 07:36AM PTC Therapeutics (PTCT) PT Lowered to $59 at Citi
May 3, 2019 04:49AM PTC Therapeutics (PTCT) PT Lowered to $59 at Citi
Jul 24, 2018 06:19AM PTC Therapeutics (PTCT) PT Raised to $50 at Citi
Apr 12, 2018 04:30PM PTC Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
Mar 29, 2018 05:39AM PTC Therapeutics (PTCT) Prices 4M Share Offering at $27.04/Sh
Mar 28, 2018 07:15PM PTC Therapeutics Announces Pricing of Public Offering of Common Stock
Mar 27, 2018 04:05PM PTC Therapeutics (PTCT) Commences 4M Share Offering of Common Stock
Mar 27, 2018 04:04PM PTC Therapeutics Announces Proposed Public Offering of Common Stock
Oct 9, 2017 09:29AM Pre-Open Movers 10/09: (CLNT) (TROV) (GEVO) Higher; (XXII) (KTWO) (PTCT) Lower (more...)
Aug 8, 2017 04:01PM PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Jul 20, 2017 08:47AM PTC Therapeutics (PTCT) PT Raised to $28 at Citi; Sees $20 Upside If Translarna is Approved
Jun 7, 2017 06:32AM PTC Therapeutics (PTCT) PT Raised to $18 at Citi, Worth $59/Share If Translama Is Approved Or $8/Share If Rejected
Nov 14, 2016 10:21AM Notable Analyst Rating Changes 11/14: (SQ) (PTCT) (CLF) Upgraded; (STI) (STLD) (RARE) Downgraded
Nov 11, 2016 12:55PM Unusual 11 Mid-Day Movers 11/11: (PTCT) (AWX) (CXRX) Higher; (PLAB) (EMAN) (HMY) Lower
Feb 24, 2016 06:54AM Citi Downgrades PTC Therapeutics (PTCT) to Neutral
Feb 23, 2016 09:30AM Pre-Open Stock Movers 02/23: (NEWP) (MMSI) (TXRH) Higher; (PTCT) (FIT) (WDC) Lower (more...)
Nov 25, 2015 10:28AM Notable Analyst Rating Changes 11/25: (PFE) (IMGN) (PANW) Upgraded; (SUNE) (PTCT) (TIF) Downgraded
Aug 25, 2015 10:32AM Notable Analyst Rating Changes 8/25: (AAPL) (BAC) (RF) Upgraded; (BOKF) (SUNE) (GAS) Downgraded
Aug 25, 2015 09:12AM UPDATE: PTC Therapeutics (PTCT) Risk/Reward Seen as Favorable, Citi Starts at Buy
Jul 30, 2015 04:05PM PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Apr 23, 2015 09:31AM Pre-Open Stock Movers 04/23: (ARRS) (DNKN) (SKX) Higher; (MOBL) (MTH) (TXN) Lower (more...)
Apr 16, 2015 10:56AM Notable Analyst Rating Changes 4/16: (COH) (INTC) (LOW) Upgraded; (AGCO) (NOK) (TRQ) Downgraded
Dec 18, 2014 07:47AM Citi Starts PTC Therapeutics (PTCT) at Buy
Oct 10, 2014 06:42AM PTC Therapeutics (PTCT) Prices 3M Common Offering at $36.25/Share
Oct 8, 2014 04:25PM PTC Therapeutics (PTCT) Announces 3M Common Stock Offering
Jul 15, 2013 10:42AM Notable Analyst Rating Changes 07/15: (LEAP) (DECK) (TIF) Upgraded; (VVUS) (UPS) (QLGC) Downgraded